Brussels, 07/03/2012 (Agence Europe) - The major emerging economies, which the stakeholder countries of the Anti-Counterfeiting Trade Agreement (ACTA) eventually wish to rally behind the treaty, have expressed their concerns to the WTO regarding the impact of several provisions of the text, particularly on access to medicines.
In an exchange of views regarding ACTA at the WTO's trade-related intellectual property aspects (TRIPS) committee on 28-29 February, a number of delegations expressed...